Skip to main content
. 2013 Apr 18;7:309. doi: 10.3332/ecancer.2013.309

Table 2. Comparing ER, PgR and HER-2/Neu status in the primary and metastatic tissue.

Brain metastasis
ER− ER+ PgR− PgR+ HER-2/Neu− HER-2/Neu+
Primary ER− 7 0 PgR− 7 1 HER-2/Neu − 10 0
ER+ 3 4 PgR+ 4 2 HER-2/Neu + 0 6

ER, estrogen receptor; PgR, progesterone receptor; HER-2+: HER-2/Neu overexpressed; HER-2−: HER-2/Neu not overexpressed